Search within:  

Sort results by:      



1-20 of 489   Next >
 
1.  
2.  
Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer. 2012 Feb 3. NGC:009822
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
3.  
Secondary prevention of ischemic heart disease and stroke in adults. 2009 Mar (revised 2014 May). NGC:010417
University of Michigan Health System - Academic Institution. View all guidelines by the developer(s)
4.  
MI - secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction. 2007 May (revised 2013 Nov). NGC:010185
National Clinical Guideline Centre - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
5.  
Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism. 2014 Dec. NGC:010622
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
7.  
Guideline on the prevention of secondary central nervous system lymphoma. 2013 Oct. NGC:009999
British Committee for Standards in Haematology - Professional Association. View all guidelines by the developer(s)
8.  
Denosumab for the prevention of osteoporotic fractures in postmenopausal women. 2010 Oct. NGC:008293
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
9.  
Clinical blood transfusion. 2011 Feb. NGC:009531
Health Sciences Authority, Singapore - National Government Agency [Non-U.S.]; Singapore Ministry of Health - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
11.  
Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (2nd edition). 2006 Jun (revised 2012). NGC:009475
Cardiac Society of Australia and New Zealand - Disease Specific Society; National Heart Foundation of Australia - Disease Specific Society; RHDAustralia - Disease Specific Society. View all guidelines by the developer(s)
14.  
15.  
Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolism. 2015 Aug. NGC:010791
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
16.  
Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care. 2003 Jul (revised 2010 Aug). NGC:008071
National Clinical Guideline Centre for Acute and Chronic Conditions - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
17.  
Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care. 2003 Sep (revised 2014 Sep). NGC:010556
National Collaborating Centre for Mental Health - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
18.  
European guidelines on cardiovascular disease prevention in clinical practice (version 2012). 2003 Dec (revised 2012 Jul). NGC:009545
European Society of Cardiology - Medical Specialty Society. View all guidelines by the developer(s)
19.  
American Association of Clinical Endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis. 2000 Mar-Apr (revised 2012 Mar-Apr). NGC:009162
American Association of Clinical Endocrinologists - Medical Specialty Society. View all guidelines by the developer(s)
20.  
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events. 2005 May (revised 2010 Dec). NGC:008658
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
1-20 of 489   Next >